{
    "2018-02-22": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报:看好估值合理的子行业龙头,重点推荐恒瑞医药、长春高新、美年健康等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "子行业龙头",
                        "恒瑞医药",
                        "长春高新",
                        "美年健康"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}